This editorial refers to 'Epicardial calcineurin -NFATsignals through Smad2 to direct coronary smooth muscle cell and arterial wall development' by J. Yang et al., this issue.
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The neural crest cells populate the outflow tract, are involved in septation of the arterial pole into the aorta and pulmonary trunk, and contribute to the smooth muscle layer of these large vessels. The pro-epicardium forms at the venous pole of the heart as a cauliflowerlike cluster, which establishes contact to the myocardial surface and through proliferation and migration rapidly invest the myocardium to establish the epicardium. The embryonic epicardium gives rise to epicardium-derived cells (EPDCs) that undergo epithelial mesenchymal transformation (EMT) and migrate into the myocardial wall to participate in coronary artery formation and to differentiate into interstitial and perivascular fibroblasts ( Figure 1) . 4 In the article by Yang et al., 3 the role of calcineurin nuclear factor of activated T cell (NFAT) signalling for smooth muscle differentiation and coronary artery wall development has been thoroughly investigated. NFATs constitute a family of transcription factors that are essential for cardiac development and their importance for cardiac valve formation and cardiac hypertrophy has been established. 5 The NFAT family consists of five genes Nfatc1 -Nfatc4 and Nfat5 of which Nfatc1, Nfatc3, and Nfatc4 are expressed in the embryonic heart. 6 When phosphorylated the NFAT proteins are kept in the cytoplasm. Signalling pathways that raise intracellular calcium causes an activation of the phosphatase calcineurin, which dephosphorylates NFATs causing nuclear import resulting in a change in gene expression ( Figure 1) . The group of Ching-Pin Chang has recently demonstrated that calcineurin signalling is essential for proper coronary vessel formation. 7 In the current study, Yang et al. 3 employed the GATA5-Cre mouse line, in order to ablate calcineurin in the epicardium. In contrast to global and endothelial, cell-specific ablation of the calcineurin gene epicardiumspecific inactivation is fully compatible with embryonic and postnatal life. However, when these animals were subjected to an exhaustive treadmill exercise the mutants displayed a reduction in exercise capacity, accompanied by a reduction in left ventricular fractional shortening and an increase in cardiac stress marker gene expression. The coronary arteries displayed specific alterations including an increased level of MMP9, collagen, and elastin expression. Moreover, the smooth muscle layer of the coronary arteries showed a specific mutant phenotype. While thickness of the media as well as cell number appeared normal, the expression levels of smooth muscle cell-specific differentiation marker genes were strongly reduced in the mutants. Cyclosporin A (CsA) treatment of embryos to test when calcineurin signalling was essential for coronary smooth muscle differentiation defined a time window between embryonic day 12.5 and 13.0. To rule out the possibility that ablation of calcineurin in differentiated smooth muscle or cardiac muscle would be responsible for the phenotype, the authors also ablated calcineurin with the Sm22a-Cre line. These mice, however, revealed no defect in coronary smooth muscle cell differentiation, which corroborates the results of the CsA experiments, suggesting that there is a specific requirement for calcineurin in the epicardium or in EPDCs. The question, which of the Nfatc genes was involved in the signalling pathway, was addressed by ablating Nfatc1 in the epicardium using GATA5-Cre. These mice did not reveal any defects in coronary smooth muscle differentiation and were fully viable ruling out that Nfatc1 is part of the pathway. The authors assume that Nfactc3 and Nfatc4 are likely to be involved; however, this was not further investigated in this study.
To identify which target gene is downstream of NFAT, different signalling pathway intermediates were tested and nuclear Smad2, which mediates TGF-b signalling, was found to be reduced in coronary smooth muscle cells of calcineurin-ablated mice. Analysis of the Smad2 promoter revealed a number of putative NFAT-binding site, which based on reporter gene assays and chromatin immunoprecipitation analysis were found to be functional (Figure 1) .
This study adds to the already large list of functions of the calcineurin-NFAT signalling pathway in the heart. Intriguingly, NFAT signalling in the embryo, therefore, is first required to establish the formation of the coronary endothelium and subsequently is involved in controlling the differentiation of EPDC-derived coronary smooth muscle cells. Such a sequential requirement of NFAT signalling in interacting tissues has also been observed for the developing valve. 8 It should be mentioned here that Nfatc1 and Nfatc3 have been implicated in balloon injury-induced neointima formation and thus this study of smooth muscle cell differentiation in cardiac development may also have its implications for vascular disease. 9, 10 There are, however, also some conflicting data in this paper, which need to be addressed in this editorial. One topic that needs attention is the use of GATA5-Cre as an epicardium-specific line. There are reports that GATA5-Cre causes an ablation of floxed genes in the developing valves. 11 Moreover, GATA5-Cre recombinase activity might even be more widespread in the embryonic heart. 12 These data cast some doubt on the specificity of the genetic approach to ablate calcineurin specifically in the epicardium. While the authors have partly addressed the specificity issues by analysing the Sm22a-Cre line and established a specific time window of calcineurin requirement through CsA treatment, it remains possible that the exercise exhaustion phenotype is not due to a specific defect in the media of coronary arteries but due to other defects. The finding in these mutants of an increased fibrosis and changes in myocardial parameter such as fractional shortening and increase in stress marker gene expression could be due to a more widespread gene inactivation. Indeed ablation of genes specifically in the epicardium has been proved to be a rather difficult achievable goal due to a lack of specificity for most of the currently available Cre-lines. Therefore, the gold standard would be to use more than one Cre-line and to demonstrate identical results with both lines. Another conflicting set of data is the lack of an embryonic phenotype after epicardial ablation of Nfatc1.
In an independent study by the Yutzey group, ablating Nfatc1 using two different epicardial Cre lines (including GATA5-Cre) resulted in lethality at embryonic day 18.5 due to a lack of cardiac fibrous matrix formation and a reduction in coronary vessel penetration in the ventricular wall. 13 The dramatically different outcomes of genetic experiments using identical mouse lines are difficult to reconcile but may be explained by strain differences. Therefore, further investigations with refined tools will be required to fully comprehend the function of the calcineurin/NFTAc pathway for the differentiation of EPDCs. Figure 1 Model of coronary smooth muscle differentiation by calcineurin/NFAT signalling. The adult myocardium consists of three tissue layers, i.e. the endocardium, myocardium, and epicardium. In the embryo, cells from the epicardium undergo EMT and form a migratory cell population, which has been termed epicardium-derived cells (EPDC). These cells will migrate into the subepicardium or into the ventricular wall and give rise to interstitial or adventitial fibroblasts and smooth muscle cells of the coronary arteries, while their contribution to the coronary endothelium is uncertain. The epicardium secretes signals (IGF2, PDGF), which stimulate myocardial proliferation resulting in chamber wall expansion, whereas the myocardium produces signals such as TGF-b and VEGF, which induce EMT and EPDCs formation. 2 Yang et al. 3 using genetic experiments in mice demonstrate that calcineurin, which activates NFAT induces Smad2 expression in EPDCs. Enhanced Smad2 expression probably sensitizes EPDCs for TGF-b, which induces differentiation of smooth muscle cells. Genetic ablation of calcineurin or NFAT in the epicardium of mice causes a loss of coronary smooth muscle differentiation leading to a reduction in exercise capacity.
Editorial
